Frank Armstrong
Chairman presso FARON PHARMACEUTICALS OY
Patrimonio netto: 118 120 $ in data 29/02/2024
Profilo
Founder of Asceneuron SA, Frank Murdoch Armstrong is a British businessperson who has been at the head of 21 different companies and currently is Non-Executive Chairman of Faron Pharmaceuticals Oy, Non-Executive Chairman of BioCaptiva Ltd., Non-Executive Chairman at Enhanc3D Genomics Ltd., Independent Chairman for Bloomsbury Genetic Therapies Ltd.
and President at Frank M Armstrong Consulting ltd.
He is also Member of The Royal College of Physicians and on the board of 6 other companies.
In the past he occupied the position of Non-Executive Chairman at Cardiorentis AG, Executive Chairman at Asceneuron SA, Non-Executive Chairman for Caldan Therapeutics Ltd., Chief Executive Officer at Phoqus Pharmaceuticals Plc and Chief Executive Officer of Phoqus Group Ltd.
(a subsidiary of Phoqus Pharmaceuticals Plc), Chief Executive Officer of Celldex Therapeutics, Inc. and President, Chief Executive Officer & Director at CuraGen Corp.
(a subsidiary of Celldex Therapeutics, Inc.), Executive Vice President-Product Development at Bayer AG, SVP-Medical Research & Communications Group at Zeneca Pharmaceuticals, Advisor at Epidarex Capital Partners LLC, Non-Executive Chairman at Summit Therapeutics Ltd., Non-Executive Chairman of Xceleron Ltd., Non-Executive Chairman at Redx Pharma Plc, Chairman at Pharmaron Abs, Inc., Chief Executive Officer at BTG Ltd., Chief Executive Officer of Fulcrum Pharma Plc, Chief Executive Officer of Bioaccelerate, Inc., Chief Executive Officer of Gardant Pharmaceuticals, Inc., Chief Executive Officer of Provensis Ltd., Senior Vice President for Merck Serono SA and Advisor at Healthcare Royalty Management LLC.
Dr. Armstrong received an undergraduate degree and a doctorate from The University of Edinburgh.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
FARON PHARMACEUTICALS OY
0.10% | 14/10/2022 | 71 062 ( 0.10% ) | 114 610 $ | 29/02/2024 |
31/03/2023 | 3 000 ( 0.00% ) | 3 510 $ | 29/02/2024 |
Posizioni attive di Frank Armstrong
Società | Posizione | Inizio |
---|---|---|
ECO ANIMAL HEALTH GROUP PLC | Director/Board Member | 01/05/2020 |
FARON PHARMACEUTICALS OY | Chairman | 16/09/2015 |
BioCaptiva Ltd.
BioCaptiva Ltd. BiotechnologyHealth Technology BioCaptiva Ltd. is a British medical device company that is developing the BioCaptis, a device that can transform liquid biopsy testing for cancer management. The company is based in Edinburgh, UK. The BioCaptis captures up to 100x more cell-free DNA (cfDNA) than a venous blood draw, yielding high-quality and quantity cfDNA for testing, which addresses the major challenge of liquid biopsy in cancer management. This will potentially allow the testing of a far greater number of cancer types and stages in a much wider range of patients. BioCaptiva was founded in 2021 when it spun out from the University of Edinburgh. The CEO is Jeremy Wheeler. | Chairman | 01/04/2021 |
Newcells Biotech Ltd.
Newcells Biotech Ltd. BiotechnologyHealth Technology Newcells Biotech Ltd. operates as a biotechnology company which produces induced pluripotent stem cells and reproducible cell and tissues. Its cell products include human neural progenitor and cardiomyocyte. The firm also provides reprogramming and differentiation services and products. The company was founded by Majlinda Lako and Lyle Armstrong in 2014 and is headquartered in Newcastle Upon Tyne, the United Kingdom. | Director/Board Member | 01/06/2019 |
The University of Edinburgh | Director/Board Member | - |
Enhanc3D Genomics Ltd.
Enhanc3D Genomics Ltd. BiotechnologyHealth Technology Enhanc3D Genomics is a British private functional genomics company that was founded in 2020 by Stefan Schönfelder, Peter Fraser, and Mikhail Spivakov. The company is based in Cambridge, UK and is developing a technology to unlock the full potential of the three-dimensional organization of the human genome. The company's unique approach focuses on the uncharted non-coding regions that make up 98% of the human genome with the aim to identify disease-associated genetic interactions, including those that are causal for disease susceptibility and progression. This technology has the potential to revolutionize target and biomarker discovery and make precision medicine an everyday reality for patients. The CEO is Debora Lucarelli. | Chairman | - |
University Court | Director/Board Member | - |
Frank M Armstrong Consulting ltd | President | 01/01/2012 |
Pharma Action GmbH
Pharma Action GmbH Pharmaceuticals: MajorHealth Technology Part of Rethmann SE & Co. KG, Pharma Action GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Berlin, Germany. The CEOs of the company are Erol Isim, Carl E. Bürger. Pharma Action was acquired by Bioibérica SA from Tönnies Lebensmittel GmbH & Co. KG on November 16, 2017. | Director/Board Member | - |
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Precedenti posizioni note di Frank Armstrong
Società | Posizione | Fine |
---|---|---|
░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Frank Armstrong
The University of Edinburgh | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 6 |
---|---|
BAYER AG | Health Technology |
ECO ANIMAL HEALTH GROUP PLC | Health Technology |
FARON PHARMACEUTICALS OY | Health Technology |
CELLDEX THERAPEUTICS, INC. | Health Services |
REDX PHARMA PLC | Health Technology |
MEREO BIOPHARMA GROUP PLC | Health Technology |
Aziende private | 33 |
---|---|
Catalent JNP, Inc.
Catalent JNP, Inc. Pharmaceuticals: MajorHealth Technology Catalent JNP, Inc. engages in the research and development of drugs and therapeutics. It offers analytical characterization and pre-formulation testing; formulation development; and clinical manufacturing of capsules and tablets. The company was founded in December 1986 and is headquartered in Somerset, NJ. | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Entelos, Inc.
Entelos, Inc. Information Technology ServicesTechnology Services Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA. | Technology Services |
Phoqus Group Ltd. | |
Phoqus Pharmaceuticals Plc
Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | Health Technology |
BTG Ltd.
BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
Fulcrum Pharma Plc
Fulcrum Pharma Plc Pharmaceuticals: OtherHealth Technology Fulcrum Pharma Plc provides drug development and regulatory expertise essential to progress a development program from research to product approval. The company was founded in 1999 and is headquartered in Hemel Hempstead, the United Kingdom. | Health Technology |
Bioaccelerate, Inc. | Finance |
Avidex Ltd.
Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | Health Technology |
Gardant Pharmaceuticals, Inc.
Gardant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gardant Pharmaceuticals, Inc. develops and commercializes pharmaceutical compounds. It develops network for research, clinical development, and project management and guides them through the clinical development and licensing stages. The company was founded in 2000 and is headquartered in New York, NY | Health Technology |
Innovate Oncology, Inc. | Health Technology |
454 Life Sciences Corp.
454 Life Sciences Corp. Medical/Nursing ServicesHealth Services 454 Life Sciences Corp. engages in the provision of medical testing services to determine the nucleotide sequence of whole genomes. The company was founded by Jonathan M. Rothberg in 2000 and is headquartered in Branford, CT. | Health Services |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Health Technology |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Finance |
Action Pharma A/S
Action Pharma A/S BiotechnologyHealth Technology Action Pharma A/S is an R&D-focused biotech company located in the Nordic Medicon Valley area in Copenhagen, Denmark. Action Pharma was founded in 2000 and has a pipeline of 4 drug candidates in different stages of development, plus additional compounds in discovery and early preclinical development. Action Pharma pursues the discovery and development of new drugs and treatment concepts to treat cardiovascular diseases, inflammatory diseases and metabolic diseases, such as type-II diabetes and obesity. Its drug candidates are modified endogenous peptides with improved efficacy and small chemical entities targeted the melanocortin receptors. In disease models, its drug candidates have shown strong effects in treating and preventing inflammation and organ damage in conditions such as post-surgical organ dysfunction and acute myocardial infarction. A major focus for Action Pharma is treatment candidates for type-II diabetes, obesity and metabolic syndrome. Moreover, several drug candidates have shown effects in treating inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and dermatitis. | Health Technology |
Provensis Ltd.
Provensis Ltd. Medical/Nursing ServicesHealth Services Part of Boston Scientific Corp., Provensis Ltd. is a British company that provides health care services. The private company is based in Camberley, UK. The company was founded in 1999 by Paul Bernard Harper. | Health Services |
Xceleron Ltd.
Xceleron Ltd. Miscellaneous Commercial ServicesCommercial Services Xceleron Ltd. provides bioanalytical Accelerator Mass Spectrometry (AMS) services for accelerated early drug development. The company uses ultra-sensitive AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I and Phase II/III clinical trials. It was founded in 1997 and is located in York, the United Kingdom. | Commercial Services |
Zeneca Pharmaceuticals
Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Health Technology |
University Court | |
TranScrip Partners LLP
TranScrip Partners LLP Pharmaceuticals: MajorHealth Technology TranScrip Partners LLP is a consultancy provider for biotech and pharmaceutical companies. TranScrip Partners was founded in 2008 and is based in Wokingham, UK. The British company offers development and commercialization services to its clients. | Health Technology |
Pharmaron Abs, Inc.
Pharmaron Abs, Inc. Pharmaceuticals: MajorHealth Technology Xceleron, Inc. provides drug development and biomedical research services. Its services include pharmaceutical and analytical method quality. The company was founded by Colin Garner in 1997 and is headquartered in Germantown, MD. | Health Technology |
Cardiorentis AG
Cardiorentis AG Pharmaceuticals: MajorHealth Technology Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland. | Health Technology |
Epidarex Capital Partners LLC
Epidarex Capital Partners LLC Investment ManagersFinance Epidarex Capital Partners LLC (Epidarex Capital) is a venture capital firm founded in 2010 by Kyparissia Sirinakisvin. The firm is headquartered in Bethesda, Maryland. | Finance |
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Health Technology |
Pharma Action GmbH
Pharma Action GmbH Pharmaceuticals: MajorHealth Technology Part of Rethmann SE & Co. KG, Pharma Action GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Berlin, Germany. The CEOs of the company are Erol Isim, Carl E. Bürger. Pharma Action was acquired by Bioibérica SA from Tönnies Lebensmittel GmbH & Co. KG on November 16, 2017. | Health Technology |
Caldan Therapeutics Ltd.
Caldan Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Caldan Therapeutics Ltd. provides novel therapeutics targeting free fatty acid. It focuses on developing drugs in order to deliver anti-diabetic effects in multiple tissues and organs. The company was founded by Graeme Milligan and Trond Ulven and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
Frank M Armstrong Consulting ltd | |
AMS Sciences Ltd.
AMS Sciences Ltd. Miscellaneous Commercial ServicesCommercial Services AMS Sciences Ltd. provides scientific and technical services. The company was founded on November 2, 2011 and is headquartered in Watfor, the United Kingdom. | Commercial Services |
Newcells Biotech Ltd.
Newcells Biotech Ltd. BiotechnologyHealth Technology Newcells Biotech Ltd. operates as a biotechnology company which produces induced pluripotent stem cells and reproducible cell and tissues. Its cell products include human neural progenitor and cardiomyocyte. The firm also provides reprogramming and differentiation services and products. The company was founded by Majlinda Lako and Lyle Armstrong in 2014 and is headquartered in Newcastle Upon Tyne, the United Kingdom. | Health Technology |
BioCaptiva Ltd.
BioCaptiva Ltd. BiotechnologyHealth Technology BioCaptiva Ltd. is a British medical device company that is developing the BioCaptis, a device that can transform liquid biopsy testing for cancer management. The company is based in Edinburgh, UK. The BioCaptis captures up to 100x more cell-free DNA (cfDNA) than a venous blood draw, yielding high-quality and quantity cfDNA for testing, which addresses the major challenge of liquid biopsy in cancer management. This will potentially allow the testing of a far greater number of cancer types and stages in a much wider range of patients. BioCaptiva was founded in 2021 when it spun out from the University of Edinburgh. The CEO is Jeremy Wheeler. | Health Technology |
Enhanc3D Genomics Ltd.
Enhanc3D Genomics Ltd. BiotechnologyHealth Technology Enhanc3D Genomics is a British private functional genomics company that was founded in 2020 by Stefan Schönfelder, Peter Fraser, and Mikhail Spivakov. The company is based in Cambridge, UK and is developing a technology to unlock the full potential of the three-dimensional organization of the human genome. The company's unique approach focuses on the uncharted non-coding regions that make up 98% of the human genome with the aim to identify disease-associated genetic interactions, including those that are causal for disease susceptibility and progression. This technology has the potential to revolutionize target and biomarker discovery and make precision medicine an everyday reality for patients. The CEO is Debora Lucarelli. | Health Technology |
Bloomsbury Genetic Therapies Ltd.
Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | Health Technology |